Brand Name :
sectral
Synonyms :
acebutolol
Class :
Anti arrhythmias II, beta blocker
Dosage Forms & Strengths
Capsule
200mg
400mg
400 - 1200
mg/day
Orally
every 12 hours
Capsule
Do not exceed 1200mg/day
400 - 1200
mg/day
Orally
every 12 hours
Capsule
400 - 1200
mg/day
Orally
every 12 hours
capsule
Do not exceed 1200mg/day
Safety and efficacy not established
Initial dose: 200-400mg/day divided orally. Do not exceed 800mg/day
Initial dose: 200-400mg/day divided orally
Do not exceed 800mg/day
Initial dose: 200-400mg/day divided orally
Do not exceed 800mg/day
may increase the hypotensive effect of anti-hypertensives
may increase the bradycardic effect
may increase the bradycardic effect of beta blockers
may increase the bradycardic effect of bradycardiac agents
may increase the hypotensive effect of anti-hypertensives
may increase the bradycardic effect of bradycardiac agents
may increase the therapeutic effect of beta blockers
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
Beta-Blockers decrease the effect of bronchiodilation of Beta2-Agonists
may decrease the antihypertensive activity
may increase the AV blocking effect of alpha2 agonists
may increase the QTc prolonging effect of QT-prolonging Class III Antiarrhythmics
may decrease the bronchodilatory effect
may increase the hypotensive effect of anti-hypertensives
may enhance the arrhythmogenic effect of bradycardia-causing agents
may increase the bradycardic effect of beta blockers
may decrease the antihypertensive effect when both drugs are combined
may enhance the anti-hypertensive effect when both drugs are combined
may decrease the bronchodilatory effect
it increases the effect of bradycardia of Beta-Blockers
beta-Blockers may enhance the adverse/toxic effect of cholinergic agonists
beta-Blockers may enhance the adverse/toxic effect of cholinergic agonists
beta-Blockers may enhance the adverse/toxic effect of cholinergic agonists
beta-Blockers may enhance the adverse/toxic effect of cholinergic agonists
beta-Blockers may enhance the adverse/toxic effect of cholinergic agonists
beta-Blockers may enhance the hypoglycemic effect of antidiabetic Agents
beta-Blockers may enhance the hypoglycemic effect of antidiabetic Agents
beta-Blockers may enhance the hypoglycemic effect of antidiabetic Agents
beta-Blockers may enhance the hypoglycemic effect of antidiabetic Agents
beta-Blockers may enhance the hypoglycemic effect of antidiabetic Agents
May enhance the hypotensive effect of beta-Blockers
May enhance the hypotensive effect of beta-Blockers
May enhance the hypotensive effect of beta-Blockers